166 related articles for article (PubMed ID: 22457516)
1. Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2.
Baldassano S; Bellanca AL; Serio R; Mulè F
J Endocrinol; 2012 Jun; 213(3):277-84. PubMed ID: 22457516
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet.
Baldassano S; Amato A; Cappello F; Rappa F; Mulè F
J Endocrinol; 2013 Apr; 217(1):11-20. PubMed ID: 23308022
[TBL] [Abstract][Full Text] [Related]
3. Complementary and antagonistic effects of combined glucagon-like peptide-2 and glucagon-like peptide-1 receptor agonist administration on parameters relevant to short bowel syndrome.
Srikrishnaraj A; Jeong H; Brubaker PL
JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1361-1370. PubMed ID: 34826336
[TBL] [Abstract][Full Text] [Related]
4. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
[TBL] [Abstract][Full Text] [Related]
5. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
[TBL] [Abstract][Full Text] [Related]
6. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
[TBL] [Abstract][Full Text] [Related]
7. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons.
Voss U; Sand E; Hellström PM; Ekblad E
BMC Gastroenterol; 2012 Apr; 12():30. PubMed ID: 22463807
[TBL] [Abstract][Full Text] [Related]
9. Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect.
Sisley S; Gutierrez-Aguilar R; Scott M; D'Alessio DA; Sandoval DA; Seeley RJ
J Clin Invest; 2014 Jun; 124(6):2456-63. PubMed ID: 24762441
[TBL] [Abstract][Full Text] [Related]
10. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
Gourcerol G; Wang L; Wang YH; Million M; Taché Y
Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
Verdich C; Flint A; Gutzwiller JP; Näslund E; Beglinger C; Hellström PM; Long SJ; Morgan LM; Holst JJ; Astrup A
J Clin Endocrinol Metab; 2001 Sep; 86(9):4382-9. PubMed ID: 11549680
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
[TBL] [Abstract][Full Text] [Related]
13. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
Williams DL; Hyvarinen N; Lilly N; Kay K; Dossat A; Parise E; Torregrossa AM
Physiol Behav; 2011 Jul; 103(5):557-64. PubMed ID: 21515295
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents.
Liu YL; Ford HE; Druce MR; Minnion JS; Field BC; Shillito JC; Baxter J; Murphy KG; Ghatei MA; Bloom SR
Int J Obes (Lond); 2010 Dec; 34(12):1715-25. PubMed ID: 20531351
[TBL] [Abstract][Full Text] [Related]
15. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
Bojanowska E; Radziszewska E
J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
[TBL] [Abstract][Full Text] [Related]
16. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
[TBL] [Abstract][Full Text] [Related]
17. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents.
Ortiz AA; Milardo LF; DeCarr LB; Buckholz TM; Mays MR; Claus TH; Livingston JN; Mahle CD; Lumb KJ
J Pharmacol Exp Ther; 2007 Nov; 323(2):692-700. PubMed ID: 17671099
[TBL] [Abstract][Full Text] [Related]
18. Impact of short and long exposure to cafeteria diet on food intake and white adipose tissue lipolysis mediated by glucagon-like peptide 1 receptor.
Mattar P; Jaque C; Teske JA; Morselli E; Kerr B; Cortés V; Baudrand R; Perez-Leighton CE
Front Endocrinol (Lausanne); 2023; 14():1164047. PubMed ID: 37293487
[TBL] [Abstract][Full Text] [Related]
19. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
20. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents.
Gourcerol G; Coskun T; Craft LS; Mayer JP; Heiman ML; Wang L; Million M; St-Pierre DH; Taché Y
Obesity (Silver Spring); 2007 Nov; 15(11):2643-52. PubMed ID: 18070755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
